ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023
ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today reported its financial and operational results for the three months ended March 31, 2023.
By ProPhase Labs, Inc.
Published - May 11, 2023, 08:10 AM ET
Last Updated - May 02, 2024, 03:03 PM EDT
As revenue mix transitions, Company still achieves positive net income and significant adjusted EBITDA while acquiring and developing biotech, genomics and diagnostic assets with multi-billion-dollar potential
Company highlights key strategic initiatives to grow underlying value in 2023 and beyond
Company to hold a conference callThursday,May11, 2023,at 11:00AM ET
Garden City, NY, May 11, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today reported its financial and operational results for the three months ended March 31, 2023.
